No Data
No Data
Is Ningbo Tianyi Medical Appliance Co., Ltd.'s (SZSE:301097) Stock Price Struggling As A Result Of Its Mixed Financials?
Abterra^ Medical (301097.SZ): The new product, disposable blood dialysis tubing, has obtained the product registration certificate.
Gelonghui October 11th | abterra^ medical (301097.SZ) announced that the company recently received the "Medical Instruments Registration Certificate" issued by the National Medical Products Administration, with the product name as Disposable Blood Dialysis Tubing. This product is an extracorporeal circulation tubing used for blood dialysis, a medical instrument sterilized with ethylene oxide for one-time use, designed to introduce the patient's blood into the blood dialyzer and blood dialysis delivery system during blood dialysis treatment. The product mainly consists of artery tubing, vein tubing, pre-chamber, storage bag, and accessory tubing. The plasticizer contained in this product's PVC tubing is DEHT. The acquisition of this product registration certificate.
Tianyi Medical Obtains Product Registration Certificate For Disposable Dialysis Set in China
Abterra^ Medical (301097.SZ): The company's new product, disposable blood dialysis tubing, has obtained the product registration certificate.
Abterra^ Medical (301097.SZ) announced on September 23 that the company recently received the Medical Instruments Registration Certificate issued by the National Medical Products Administration. Product name: Disposable Blood Dialysis Tubing; Registration certificate number: National Machinery Standard 20243101815; Registration category: Class III; Validity period of registration certificate: September 19, 2024 to September 18, 2029; Expected use: This product is used as a blood channel for blood dialysis, blood filtration, and blood dialysis filtration mode treatment of patients with acute and chronic renal failure.
At present, abterra^ Medical (301097.SZ): the company's series of enteral nutrition products exported to the USA are not on the tariff list announced by the USA.
Gelonghui September 20th | Abterra^ Medical (301097.SZ) stated on the investor interaction platform that we have noticed that the Office of the United States Trade Representative (USTR) released the final details of the new 301 tariffs on China on September 13. At present, the company's series of intestinal nutrition products exported to the usa are not included in the tax list announced by the U.S. this time.
Abterra^ Medical (301097.SZ): has repurchased 2.42% of the shares.
On September 2nd, Gelonghui announced that as of August 31, 2024, Tianyi Medical (301097.SZ) had repurchased a total of 1,427,400 shares of the company through the stock trading system of the Shenzhen Stock Exchange, accounting for 2.42% of the current total share capital of the company. The highest fill price was 42.80 yuan per share, and the lowest fill price was 32.71 yuan per share. The total transaction amount was 57.6413 million yuan (excluding stamp duty, trading commission, and other transaction costs).
No Data
No Data